(NYSE: BAK) Braskem Sa's forecast annual revenue growth rate of 4.41% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 2.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.61%.
Braskem Sa's revenue in 2025 is $13,439,409,722.On average, 2 Wall Street analysts forecast BAK's revenue for 2025 to be $10,885,159,472,259, with the lowest BAK revenue forecast at $10,492,514,683,818, and the highest BAK revenue forecast at $11,277,804,260,699. On average, 2 Wall Street analysts forecast BAK's revenue for 2026 to be $12,096,528,734,139, with the lowest BAK revenue forecast at $11,349,600,798,229, and the highest BAK revenue forecast at $12,843,456,670,049.
In 2027, BAK is forecast to generate $11,847,887,582,793 in revenue, with the lowest revenue forecast at $11,847,887,582,793 and the highest revenue forecast at $11,847,887,582,793.